28
Oct
2025

Linnea SA

Exhibitor at CPHI Frankfurt 2025 stand 9.1D78, Integrated Pharma
About Us

Linnea has been manufacturing high quality botanical ingredients for over 40 years in our GMP certified facility located in Ticino, Switzerland. We sell to over 70 different countries all over the globe and serve more than 300 businesses each year. With a focus on sustainability and the environment we produce natural botanical extracts, isolates, and ready made oil solutions. Since 1982 Linnea has been providing these unparalleled ingredients for use in the pharmaceutical, cosmetics and dietary ingredient industries. Linnea’s core mission is to improve peoples quality of life.

  • CH
  • 2015
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 9.1D78, Integrated Pharma

Products Featured at CPHI Frankfurt 2025

  • Red Clover

    Product Red Clover

    Linnea’s Red Clover botanical extract is extracted using a unique formula, balancing the main four Red Clover isoflavones,consistent through every batch. Linnea thus ensures consistent quality and standardization of Red Clover. 
  • Vincamine

    Product Vincamine

    Vincamine is a semi-synthetic derivative, extracted using a proprietary methodto Linnea, vetted to GMP-standard quality controls, obtaining a state-of-theartproduct. Vincamine is CEP certified, and complies with Ph.Eur. monograph“Vincamine”, that Linnea developed.
  • Vinpocetine

    Product Vinpocetine

    Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified.
  • Butylscopolamine

    Product Butylscopolamine

    Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified.
  • Cannabinoids

    Product Cannabinoids

    A treasure trove of active ingredients just waiting to be rediscovered. Linnea’s therapeutic Cannabinoid solutions are the culmination of more than four decades of experience and unrivaled attention to quality. Linnea' CBD is compliant with the new Ph. Eur. Monograph.
  • 5 HTP

    Product 5 HTP

    5-hydroxytryptophan is an amino-acid with nootropic and antidepressant actions,naturally present in the brain and found in food in small doses. Exogenous therapeutic 5 HTP is isolated from the seeds of the African plant Griffonia simplicifolia.
  • Bilberry

    Product Bilberry

    Grown in forests in Northern Europe, our antioxidant-rich bilberries are transformed into GMP certified and approved dry extracts. 
  • Ginkgo biloba

    Product Ginkgo biloba

    Linnea’s Ginkgo Biloba dry extract is derived in two different methods, allowing to obtain two different products, Ginkgo Biloba EPG 246, and Ginkgo Biloba Ethanol,suitable for pharmaceutical and food applications respectively, with comparable activity. Linnea's Ginkgo Biloba complies with the current edit...
  • HMRlignan®

    Product HMRlignan®

    HMRlignan® is extracted from the Picea abies L. (Norway Spruce) plant.The raw material is harvested in a sustainable way, working with local forestry commissions and authorities. Linnea has a special extraction method and its HMRlignan® has a unique activity as a result.